The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of ixazomib (Ix) pomalidomide (POM) dexamethasone (DEX) in relapsed refractory (R/R) multiple myeloma: Initial results.
 
Amrita Y. Krishnan
Stock and Other Ownership Interests - Celgene (I); Infinity Pharmaceuticals (I)
Consulting or Advisory Role - Celgene; Janssen Oncology; Onyx; Spectrum Pharmaceuticals; Takeda
Speakers' Bureau - Celgene; Janssen Oncology; millennium; onyx
Research Funding - Celgene (Inst); takeda (Inst)
 
Prashant Kapoor
Research Funding - Amgen (Inst); Celgene (Inst); Takeda (Inst)
 
Joycelynne Palmer
No Relationships to Disclose
 
Shaji Kumar
Consulting or Advisory Role - Kedrion Biopharma; Noxxon Pharma; Skyline Diagnostics
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen-Ortho (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
 
Sagar Lonial
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Millennium; Novartis; Onyx; Sanofi
 
Myo Htut
Consulting or Advisory Role - Takeda
 
Chatchada Karanes
No Relationships to Disclose
 
Nitya Nathwani
No Relationships to Disclose
 
Michael Alan Rosenzweig
Speakers' Bureau - Celgene
 
Firoozeh Sahebi
No Relationships to Disclose
 
George Somlo
Other Relationship - Abbvie
 
Lupe Duarte
No Relationships to Disclose
 
Stephen J. Forman
No Relationships to Disclose
 
Jesus G. Berdeja
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Curis (Inst); Janssen-Ortho (Inst); Novartis (Inst); Takeda (Inst)